FDA Approval
Rakuten Medical Closes $100 Million Series F to Push Lead Cancer Therapy Toward FDA Review
2026-01-09
FDA Approves PADCEV and Keytruda Perioperative Therapy: A Game-Changer for Cisplatin-Ineligible Bladder Cancer Patients
2025-11-27
FDA Approves Roche’s Gazyva for Lupus Nephritis, Bringing New Hope to 1.7 Million Patients Worldwide
2025-10-21
Eli Lilly’s Oral GLP-1 Weight-Loss Pill Clears Third Phase 3 Trial, Bringing FDA Approval Within Reach
2025-08-27
FDA Approval of First-in-Class BRINSUPRI Offers New Hope for Hundreds of Thousands with Chronic Lung Disease
2025-08-12
FDA Approval of KETARx Unlocks New Era of Ketamine Treatments for Pain Mental Health and Neurological Disorders
2025-08-12
After Deaths and a Pause, Sarepta Restarts ELEVIDYS Shipments After FDA Review Eases Safety Concerns
2025-07-29
Psychedelics Are Driving a Mental Health Revolution with Long-Lasting Therapeutic Potential
2025-06-17
LATEST
WCC BIOMEDICAL Overcomes Microneedle Array Patches Manufacturing Challenges, Advancing Next-Generation Drug Delivery
2026-07-18
Texas Tech Veterinary Students Publish Independent Research on Equine Genomics and Veterinary Science
2026-07-17
EVENT
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan





